BioNTech SE (BNTX)
103.81
+1.86
(+1.83%)
USD |
NASDAQ |
Sep 02, 16:00
103.81
0.00 (0.00%)
After-Hours: 19:28
BioNTech Research and Development Expense (Annual) : 2.376B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.376B |
| December 31, 2024 | 2.438B |
| December 31, 2023 | 1.928B |
| December 31, 2022 | 1.564B |
| December 31, 2021 | 1.083B |
| Date | Value |
|---|---|
| December 31, 2020 | 676.96M |
| December 31, 2019 | 222.66M |
| December 31, 2018 | 147.15M |
| December 31, 2017 | 85.31M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Moderna, Inc. | 2.917B |
| Biodexa Pharmaceuticals Plc | 5.026M |
| NuCana Plc | 16.79M |
| Mereo BioPharma Group Plc | 17.81M |
| MediGene AG | -- |